DECHENG CAPITAL MANAGEMENT III (CAYMAN), LLC – Terns Pharmaceuticals, Inc. Transaction History
DECHENG CAPITAL MANAGEMENT III (CAYMAN), LLC portfolio value:
$4.20M
portfolio value
DECHENG CAPITAL MANAGEMENT III (CAYMAN), LLC quarter portfolio value change:
+137.50%
quarter
Terns Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 2.43M | $5.89 | 714.28K | |
| Q2 2022 | share | 0.00% | 0 shares | -350K | $2.48 | 714.28K | |
| Q1 2022 | share | Increase | 0.00% | 714.28K shares | 2.12M | $2.97 | 714.28K |